Market research
NATHBIOGEN.NSE Nath Bio-Genes (India) Limited
NSE INR Basic Materials
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 3B
- P/E ratio
- 6.7
- Analyst target
- Not available
- Dividend yield
- Not available
- Beta
- 0.84
Community
Investor discussion
1 comment
Sign in to join the NATHBIOGEN.NSE discussion.
5 years, 5 months ago
Nath Bio-Genes (India) Limited is currently in a long term uptrend where the price is trading 18.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.9% cheaper than other stocks from the Basic Materials sector with a price to sales ratio of 2.2.
Nath Bio-Genes (India) Limited's total revenue rose by 9.0% to $360M since the same quarter in the previous year.
Its net income has increased by 8.8% to $42M since the same quarter in the previous year.
Finally, its free cash flow grew by 8.3% to $-71M since the same quarter in the previous year.
Based on the above factors, Nath Bio-Genes (India) Limited gets an overall score of 5/5.